GTS-21, an α7nAChR agonist, increases pulmonary bacterial clearance in mice by restoring hyperoxia-compromised macrophage function

Samankaltaisia teoksia

• The α7 Nicotinic Acetylcholine Receptor Agonist GTS-21 Improves Bacterial Clearance in Mice by Restoring Hyperoxia-Compromised Macrophage Function
  Tekijä: Sitapara, Ravikumar A, et al.
  Julkaistu: (2014)
• Expression of Concern to: The α7 nicotine acetylcholine receptor agonist GTS-21 improves bacterial clearance in mice by restoring hyperoxia-compromised macrophage function
  Tekijä: Sitapara, Ravikumar A., et al.
  Julkaistu: (2020)
• Retraction Note: The α7 nicotinic acetylcholine receptor agonist GTS-21 improves bacterial clearance in mice by restoring hyperoxia-compromised macrophage function
  Tekijä: Sitapara, Ravikumar A., et al.
  Julkaistu: (2020)
• The α7 nicotinic acetylcholine receptor agonist, GTS-21, attenuates hyperoxia-induced acute inflammatory lung injury by alleviating the accumulation of HMGB1 in the airways and the circulation
  Tekijä: Ravikumar A. Sitapara, et al.
  Julkaistu: (2020-06-01)
• The α7 nicotinic acetylcholine receptor agonist, GTS-21, attenuates hyperoxia-induced acute inflammatory lung injury by alleviating the accumulation of HMGB1 in the airways and the circulation
  Tekijä: Sitapara, Ravikumar A., et al.
  Julkaistu: (2020)